CLAR Clarus Corp Insider Trading

CFO Yates buys 15,000 CLAR shares in 2 transactions ($3.20–$3.40); cluster of 3 insiders buying within 14 days amid -7.6% revenue decline.

Michael J Yates, Chief Financial Officer, executed 2 separate purchases totaling 15,000 shares for $49,759.12 at prices of $3.20 and $3.40, increasing his holdings by 60.0% from 25,000 to 40,000 shares. This buying activity occurred alongside purchases by 2 other insiders within the past 14 days, forming a cluster pattern. The company is operating unprofitably (net income $-8.4M in the latest quarter, negative full-year net income) and revenue is declining year-over-year at -7.6%, while the stock trades 34.6% below its 52-week high of $5.18. The combination of executive-level accumulation during a period of financial deterioration and broad insider buying across multiple parties warrants attention to the underlying drivers motivating these acquisitions.

Warren Kanders buys 289,000 shares at avg $3.24 (total $935.7K) as CLAR trades 39.6% below 52-week high

Warren Kanders, Executive Chairman, acquired 289,000 shares across 2 separate transactions on 2025-08-05 and 2025-08-06 at prices of $3.24 and $3.23, totaling $935,690.40, raising his holdings to 4,444,326 shares. The purchases occurred when the stock was trading at $3.13, down 39.6% from its 52-week high of $5.18 and down 12.3% over the prior 30 days, suggesting a directional move lower in the recent period. At the same-ticker level, Kanders' two prior purchases at CLAR (2025-06-23 and 2025-06-20) posted 30-day returns of 14.7% and 2.6% respectively, though neither has yet recorded a measurable 90-day outcome. His cross-ticker buying track record shows 2 prior buys with an average 30-day return of 8.6%, indicating some historical correlation between his buy activity and near-term positive returns. However, the company fundamentals are challenged: CLAR posted revenue of $55,247,000.00 with a net loss of $8,434,000.00 in the latest quarter, annual revenue contracted 7.6% year-over-year, and the firm was unprofitable over its most recent full fiscal year, creating a backdrop of deteriorating operational performance that tempers the significance of insider accumulation at a heavily discounted price point.

Director SOKOLOW NICOLAS bought 20,000 shares of CLAR at $3.25 on 2025-08-05; stock now -39.6% from 52-week high, company unprofitable.

Director SOKOLOW NICOLAS purchased 20,000 shares at $3.25, raising his holdings by 3.4% to 600,311 shares. The company is structurally unprofitable (net income $-8.4M) with revenue declining 7.6% year-over-year, and the stock has declined 12.3% over the past 30 days and sits 39.6% below its 52-week high of $5.18. At this same ticker, SOKOLOW's prior 5 buys show mixed results: 2 of 5 were well-timed at the 90-day mark, with returns ranging from -16.5% to +13.7% over 30 days. His cross-ticker track record across 8 prior buys shows an average 90-day return of -3.8% with only a 25.00% win rate. The purchase follows a period of deteriorating fundamentals and sustained price weakness, without clear evidence of successful prior timing at this ticker.

Executive Chairman Kanders bought 11,399 shares at $3.48–$3.50 avg; stock -47.4% from 52-week high, company unprofitable.

Warren Kanders purchased 11,399 shares in 2 separate transactions totaling $39,686.54 on 2025-06-20 and 2025-06-23, adding 0.3% to his 4.16M-share position. Clarus Corp is unprofitable with a $-5.2M net loss in its most recent full fiscal year and -7.6% annual revenue growth, while trading 47.4% below its 52-week high of $6.73. Kanders' cross-ticker track record shows 20 prior open-market sells with a well-timed rate of 33.33%, indicating he has historically struggled with timing; his average 90-day return after those sales was +3.6%, suggesting his prior sells preceded stock gains he did not capture. The modest size of this purchase relative to his existing position, combined with deteriorating fundamentals and depressed valuation, provides limited evidence of conviction.

Director Sokolow purchases 22,000 CLAR shares at $4.09; stock down -44.5% from 52-week high amid unprofitable operations and -7.6% revenue decline.

Nicolas Sokolow, a director of Clarus Corp, purchased 22,000 shares at $4.09 on 2025-03-11, increasing his holdings by 22,000 shares (+3.9% vs pre-transaction holdings). The purchase occurs in a backdrop of depressed valuation and operational headwinds: the stock is -44.5% from its 52-week high of $7.31, down -15.2% over the prior 30 days and -19.3% over 90 days. Fundamentals show CLAR generated $67.1M in quarterly revenue but posted a net loss of $3.2M, with full-year results negative and annual revenue declining -7.6% year-over-year. Among Sokolow's same-ticker history at CLAR, 2 of 5 prior buys (both on back-to-back dates in November 2024) achieved positive 90-day returns (+12.3% and +13.7%), while 3 others were underwater at the 90-day mark, suggesting mixed timing precision at this ticker. His cross-ticker track record shows 7 buys with an average 90-day return of -2.3%, indicating this insider's historical buying has not consistently generated outperformance. The transaction reflects a continued accumulation strategy in a company facing both operational losses and price weakness, without clear evidence of value-recognition timing.

Director Sokolow purchases 100,000 shares of CLAR in two transactions for $442,500; stock down 41.2% from 52-week high, his prior CLAR buys showed 90d losses.

Nicolas Sokolow, a Director at Clarus Corp, executed 2 separate purchases totaling 100,000 shares for $442,500.00, increasing his holdings from 458,311 to 558,311 shares (+21.8%). The buys occurred on 2024-11-12 at $4.37 and 2024-11-13 at $4.48, with a blended average price of $4.42; the current price of $4.30 sits 41.2% below the 52-week high of $7.31. Notably, his prior trades at CLAR show a consistent pattern of losses: 5 prior buys at this ticker posted 0 of 5 well-timed outcomes at the 90-day mark, with returns ranging from -15.0% to -5.3%. The company is unprofitable (full-year net income was negative, latest quarter recorded net income of $-3,157,000.00), with annual revenue declining 36.2%, and trades at a P/E of 33.08 despite negative earnings. This purchase breaks no new pattern: Sokolow is increasing exposure to a declining stock at a company facing both operational headwinds and a historical record of ill-timed entry points at this ticker.

Warren Kanders buys 18,400 shares of CLAR at $4.31 (Sept 11), 4th purchase in 3 days amid -36.2% revenue decline and negative earnings.

Kanders (Executive Chairman) purchased 18,400 shares at $4.31 on September 11, marking the fourth discrete buy in CLAR within three trading days (September 6, 9, 10, and 11). The consolidated purchases suggest sustained acquisition despite deteriorating fundamentals: annual revenue fell -36.2% year-over-year, the company posted net income of $-5,493,000.00 for the latest quarter, and full-year net income was negative. The stock is currently down -40.5% from its 52-week high of $7.56 and has declined -31.4% over the past 90 days, though it has risen +4.4% over 30 days. His cross-ticker track record shows only 3 prior buys against 14 prior sells, with sells averaging a 90-day well-timed rate of 8.33%—a weak buying signal relative to his demonstrated sell discipline. With no measurable 90-day outcomes yet available for his same-ticker trades at CLAR, the timing and conviction-value of this rapid accumulation remain unproven in context of the company's sharply deteriorating operational performance and unprofitable status.

Clarus Executive Chairman purchases 280,000 shares at $4.14 blended average; stock down 46.6% from 52-week high amid revenue decline and losses.

Warren B Kanders executed 3 separate open-market purchases totaling 280,000 shares for $1,160,034.00 between September 6–10, 2024, at prices ranging from $4.00 to $4.19, bringing his post-transaction holdings to 4,125,527 shares. The timing is notable: the stock is currently trading at $4.04, down 46.6% from its 52-week high of $7.56 and down 41.4% over the prior 90 days, while the company faces significant headwinds including -36.2% annual revenue growth and negative net income of $-5,493,000.00 in the latest quarter. Across his cross-ticker track record, Kanders's prior 14 open-market sales showed poor timing characteristics (average 90-day return of +12.7%, indicating the stock rose after he sold). This purchase occurs at depressed price levels following extended decline, but the company's deteriorating fundamentals and ongoing losses contextualize the signal carefully.

Director Sokolow buys 26,500 shares of CLAR at $4.88; stock down 51.0% from 52-week high and now -51.0% YTD; company unprofitable with -36.2% annual revenue decline.

Sokolow, a director, purchased 26,500 shares on 2024-08-06 at $4.88, increasing holdings to 438,311 shares. The stock has since declined to $4.46 (current price), down 51.0% from its 52-week high of $9.11 and down 34.1% over the past 90 days. Clarus Corp reported net income of -5,493,000.00 and annual revenue growth of -36.2%, indicating significant operational stress. His prior SAME-TICKER HISTORY shows 4 buys at this stock with a 0.00% win rate at the 90-day mark—all prior purchases resulted in negative returns within 90 days, averaging -5.6% loss. This latest purchase at $4.88 has already declined roughly 8.6% to the current $4.46, extending his pattern of poor timing on CLAR purchases.